Skip to content

Opening book details…

About this Medicine article

Pharmacological action and clinical results of Omarigliptin (MARIZEV® tablet), a novel dipeptidyl peptidase-4 inhibitor for once-weekly treatment of Type 2 diabetes by Ito, Yuka; Mori, Masahiko; Matsumoto, Yuki; Okamoto, Taro is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Ito, Yuka; Mori, Masahiko; Matsumoto, Yuki; Okamoto, Taro
Publisher
Japan Science and Technology Information Aggregator, Electronic; The Japanese Pharmacological Society; Nippon Yakuri Gakkai; Japanese Pharmacological Society (ISSN 0015-5691)
Published
2017
Field
Medicine (Life Sciences)